Pål Aukrust

42.3k citations
869 papers · 35.5k · 4 hit papers · h-index 93

Impact in

Papers in

    • Atherosclerosis and Cardiovascular Diseases 95
    • Immunodeficiency and Autoimmune Disorders 50
    • Cardiac Fibrosis and Remodeling 108
    • Heart Failure Treatment and Management 73
    • Acute Myocardial Infarction Research 44

Pål Aukrust

851 papers receiving 34.6k citations

Pål Aukrust's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 290 citations
2900+4+8Years since publication100200300400

Peers

Pål Aukrust
Comparison fields: 5 of 162
  • Biological Psychiatry 758
  • Immunology 6.2k
  • Cardiology and Cardiovascular Medicine 7.1k
  • Virology 1.2k
  • Epidemiology 3.1k
Replace Thor Ueland with:
Thor Ueland Norway
Hans‐Dieter Volk Germany
Jörg J. Goronzy United States
Cornelia M. Weyand United States
Douglas L. Mann United States
Steven L. Kunkel United States
Carl Grünfeld United States
Erik S. G. Stroes Netherlands
Göran K. Hansson Sweden
Cornelis Erik Hack Netherlands
Pål Aukrust relative to Thor Ueland Norway Thor Ueland's profile →
Citations per field
00.5×2×4×6.0×
Thor Ueland · 1×
Citations per year

Countries citing papers authored by Pål Aukrust

Since Specialization
Citations

This map shows the geographic impact of Pål Aukrust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pål Aukrust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pål Aukrust more than expected).

Fields of papers citing papers by Pål Aukrust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pål Aukrust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pål Aukrust. The network helps show where Pål Aukrust may publish in the future.

Co-authors

The 25 scholars most cited alongside Pål Aukrust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pål Aukrust Line = papers co-authored together Pål Aukrust links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 869 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006517
2 2013463
3 1999439
4 2007411
5
Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure
Hit paper breakdown →
2014405
6 1999388
7 2016360
8
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
Hit paper breakdown →
2021350
9 1998323
10
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Hit paper breakdown →
2016321
11 2020305
12 2001303
13 2012300
14
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022290
15 2009277
16 2016275
17 1994259
18 2006251
19 2009251
20 2016228

About Pål Aukrust

Pål Aukrust is a scholar working on Immunology, Cardiology and Cardiovascular Medicine, Virology, Biological Psychiatry and Epidemiology, having authored 869 papers that have together received 35.5k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (108 papers), Atherosclerosis and Cardiovascular Diseases (95 papers), Heart Failure Treatment and Management (73 papers), HIV Research and Treatment (55 papers), Immunodeficiency and Autoimmune Disorders (50 papers), Acute Myocardial Infarction Research (44 papers), Lipoproteins and Cardiovascular Health (40 papers) and Tryptophan and brain disorders (32 papers). The work is most often cited by research in Biological Psychiatry (758 citations), Immunology (6.2k citations), Cardiology and Cardiovascular Medicine (7.1k citations), Virology (1.2k citations) and Epidemiology (3.1k citations). Pål Aukrust has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Thor Ueland, Lars Lysgaard Gullestad, Stig Sophus Frøland, Arne Yndestad, Fredrik Müller, Bente Lise Halvorsen, Jan Kristian Damås, Terje Espevik, Erik Øie and Egil Lien. Their work appears in journals such as PLoS ONE, Clinical & Experimental Immunology, International Journal of Cardiology, Atherosclerosis and Journal of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact